NAT2 Antibody

• Background:

  This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2) .

• NCBI Gene ID:

  10

• Swiss Prot:

  P11245

• Host:

  Rabbit

• Reactivity:

  Human, Mouse, Rat

• Immunogen:

  Recombinant fusion protein containing a sequence corresponding to amino acids 171-290 of human NAT2 (NP_000006.2) .

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Cancer, Signal Transduction

• Purification:

  Affinity purification

• Positive Control:

  293T

• Concentration:

  Batch dependent

• Buffer:

  PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at -20˚ C. Avoid freeze / thaw cycles.

• Calculated Molecular Weight:

  Observed: 36kDa

• Fragment:

  IgG

• Symbol:

  NAT2

• Positive Control 2:

  Mouse heart

• Positive Control 3:

  Mouse liver

• Positive Control 4:

  Mouse kidney

• NCBI Official Name:

  N-acetyltransferase 2 (arylamine N-acetyltransferase)

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  NAT2, AAC2, PNAT, NAT-2

• Tested Applications:

  WB, IHC, IF

• Physical Properties:

  Liquid